These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1198 related articles for article (PubMed ID: 12548325)

  • 21. The role of topical immune response modifiers in skin cancer.
    Woodmansee C; Pillow J; Skinner RB
    Drugs; 2006; 66(13):1657-64. PubMed ID: 16978032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.
    Papadavid E; Stratigos AJ; Falagas ME
    Expert Opin Pharmacother; 2007 Aug; 8(11):1743-55. PubMed ID: 17685890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
    Hengge UR; Cusini M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5% topical imiquimod tolerance in transplant recipients.
    Ben M'barek L; Mebazaa A; Euvrard S; Frances C; Thervet E; Morel P; Menasché S; Legendre C; Lebbe C
    Dermatology; 2007; 215(2):130-3. PubMed ID: 17684375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful management of viral infections and other dermatoses with imiquimod 5% cream.
    Berman B; Hengge U; Barton S
    Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):12-7. PubMed ID: 14606277
    [No Abstract]   [Full Text] [Related]  

  • 26. Imiquimod 5% cream for actinic keratosis.
    Perras C
    Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imiquimod in the treatment of cutaneous warts: an evidence-based review.
    Ahn CS; Huang WW
    Am J Clin Dermatol; 2014 Oct; 15(5):387-99. PubMed ID: 25186654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What's new in pediatric dermatology: update for the pediatrician.
    Sidbury R
    Curr Opin Pediatr; 2004 Aug; 16(4):410-4. PubMed ID: 15273502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of topical therapies in the management of cutaneous disease.
    Skinner R
    J Cutan Med Surg; 2004; 8 Suppl 3():22-31. PubMed ID: 15647859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum.
    Hengge UR; Esser S; Schultewolter T; Behrendt C; Meyer T; Stockfleth E; Goos M
    Br J Dermatol; 2000 Nov; 143(5):1026-31. PubMed ID: 11069514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential.
    Stanley MA
    Clin Exp Dermatol; 2002 Oct; 27(7):571-7. PubMed ID: 12464152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulatory and pharmacologic properties of imiquimod.
    Sauder DN
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S6-11. PubMed ID: 10861101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythroplasia of Queyrat treated with imiquimod 5% cream.
    Micali G; Nasca MR; De Pasquale R
    J Am Acad Dermatol; 2006 Nov; 55(5):901-3. PubMed ID: 17052503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream.
    Micali M; Nasca MR; Musumeci ML
    Int J Tissue React; 2005; 27(3):111-4. PubMed ID: 16372477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunocompromised woman with severe molluscum contagiosum that responded well to topical imiquimod: a case report and literature review.
    Lin HY; Linn G; Liu CB; Chen CJ; Yu KJ
    J Low Genit Tract Dis; 2010 Apr; 14(2):134-5. PubMed ID: 20354423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of topical imiquimod for the treatment of actinic keratosis: a status report.
    Del Rosso JQ
    Cutis; 2005 Oct; 76(4):241-8. PubMed ID: 16315560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of molluscum contagiosum with imiquimod 5% cream.
    Skinner RB
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S221-4. PubMed ID: 12271282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased number of mast cells in the dermis in actinic keratosis lesions effectively treated with imiquimod.
    Oyama S; Funasaka Y; Tsuchiya SI; Kawana S; Saeki H
    J Dermatol; 2017 Aug; 44(8):944-949. PubMed ID: 28342266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of imiquimod-induced alopecia.
    Conde J; Davis K; Ntuen E; Balmer N; Jones D; McMichael A
    J Dermatolog Treat; 2010 Mar; 21(2):122-4. PubMed ID: 19488918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imiquimod 5% cream for the treatment of cutaneous lesions in immunocompromised patients.
    Johnson R; Stockfleth E
    Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):23-7. PubMed ID: 14606279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.